Artelo Biosciences Inc. Warrant (ARTLW) Key Ratios
$0.01
As on 17-Jun-2024 16:00EDT
Market cap
$0 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | -- | -- | -- |
| Net Profit | 19.20 | -21.48 | 5.92 | -83.55 | -214.45 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-23 | Dec-22 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | -- | -59.63 | -50.89 |
| Return on Capital
| -- | -- | -- | -59.51 | -50.81 |
| Return on Assets
| -- | -- | -- | -55.51 | -48.35 |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
-59.51
|
-50.72
|
-50.81
|
-63.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
-59.63
|
-50.89
|
-50.89
|
-64.13
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
--
--
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
-55.51
|
-48.35
|
-48.35
|
-61.00
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
--
|
-38.25
|
--
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
5.92
|
2.07
|
-32.77
|
-35.58
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
0.00
|
0.00
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
0.00
|
0.00
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
11.36
Higher than Peers by 5.55
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
11.36
|
8.51
|
18.36
|
18.36
|
18.36
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
11.36
Higher than Peers by 5.66
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
11.36
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
-2,057.40
|
-2,057.40
|
--
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
--
|
--
|
1.70
|
1.70
|
1.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 142
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-23
|
Aug-23
|
Dec-22
|
Aug-22
|
|---|---|---|---|---|---|
|
Artelo Biosciences Inc. Warrant (ARTLW)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|